Global Blood Plasma Derivatives Market: Development History, Current Analysis and Estimated Forecast to 2025

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

Access Report Details at:

The global Blood Plasma Derivatives market is valued at 24800 million US$ in 2018 is expected to reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025.

This report focuses on Blood Plasma Derivatives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Plasma Derivatives market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Blood Plasma Derivatives Market report are Grifols, Sk Plasma, Fusion Health Care, Biotest Ag, Green Cross Corporation, Baxter International, Lfb, Octapharma Ag, Csl Limited, Shire Plc., China Biologic Products, KedrionBiopharma, BdiPharma, Bayer Ag, Hualan Biological Engineeringand more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at:

Table of Content

1 Blood Plasma Derivatives Market Overview

2 Global Blood Plasma Derivatives Market Competition by Manufacturers

3 Global Blood Plasma Derivatives Production Market Share by Regions

4 Global Blood Plasma Derivatives Consumption by Regions

5 Global Blood Plasma Derivatives Production, Revenue, Price Trend by Type

6 Global Blood Plasma Derivatives Market Analysis by Applications

7 Company Profiles and Key Figures in Blood Plasma Derivatives Business

8 Blood Plasma Derivatives Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global Blood Plasma Derivatives Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source

Leave a Reply

Your email address will not be published. Required fields are marked *